Synergistic combination therapy using a lipid shell-droplet core nanosphere with tunable thickness

Chia Wei Su; Ting Hsi Fan; Wei Ming Li; San-Yuan Chen

doi:10.1039/c4cc02717e

Synergistic combination therapy using a lipid shell-droplet core nanosphere with tunable thickness

Chia Wei Su, Ting Hsi Fan, Wei Ming Li, San-Yuan Chen^*

^*此作品的通信作者

材料科學與工程學系

研究成果: Article › 同行評審

2 引文斯高帕斯（Scopus）

摘要

A newly-designed drug carrier composed of an internal droplet core and a thickness-controllable shell was successfully developed. By co-delivering paclitaxel, doxorubicin and quantum dots simultaneously, this combinational drug delivery system could achieve in vitro fluorescence imaging, chemotherapeutic and oxidation therapy.

原文	English
頁（從 - 到）	11291-11294
頁數	4
期刊	Chemical Communications
卷	50
發行號	77
DOIs	https://doi.org/10.1039/c4cc02717e
出版狀態	Published - 1 1月 2014

存取文件

10.1039/c4cc02717e

其它文件與鏈接

Link to publication in Scopus

引用此

@article{1bf0ed64d2674e0891c8acce3ef04803,

title = "Synergistic combination therapy using a lipid shell-droplet core nanosphere with tunable thickness",

abstract = "A newly-designed drug carrier composed of an internal droplet core and a thickness-controllable shell was successfully developed. By co-delivering paclitaxel, doxorubicin and quantum dots simultaneously, this combinational drug delivery system could achieve in vitro fluorescence imaging, chemotherapeutic and oxidation therapy.",

author = "Su, {Chia Wei} and Fan, {Ting Hsi} and Li, {Wei Ming} and San-Yuan Chen",

year = "2014",

month = jan,

day = "1",

doi = "10.1039/c4cc02717e",

language = "English",

volume = "50",

pages = "11291--11294",

journal = "Chemical Communications",

issn = "1359-7345",

publisher = "Royal Society of Chemistry",

number = "77",

}

TY - JOUR

T1 - Synergistic combination therapy using a lipid shell-droplet core nanosphere with tunable thickness

AU - Su, Chia Wei

AU - Fan, Ting Hsi

AU - Li, Wei Ming

AU - Chen, San-Yuan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - A newly-designed drug carrier composed of an internal droplet core and a thickness-controllable shell was successfully developed. By co-delivering paclitaxel, doxorubicin and quantum dots simultaneously, this combinational drug delivery system could achieve in vitro fluorescence imaging, chemotherapeutic and oxidation therapy.

AB - A newly-designed drug carrier composed of an internal droplet core and a thickness-controllable shell was successfully developed. By co-delivering paclitaxel, doxorubicin and quantum dots simultaneously, this combinational drug delivery system could achieve in vitro fluorescence imaging, chemotherapeutic and oxidation therapy.

UR - http://www.scopus.com/inward/record.url?scp=84907087555&partnerID=8YFLogxK

U2 - 10.1039/c4cc02717e

DO - 10.1039/c4cc02717e

M3 - Article

C2 - 24875625

AN - SCOPUS:84907087555

SN - 1359-7345

VL - 50

SP - 11291

EP - 11294

JO - Chemical Communications

JF - Chemical Communications

IS - 77

ER -

Synergistic combination therapy using a lipid shell-droplet core nanosphere with tunable thickness

摘要

存取文件

其它文件與鏈接

指紋

引用此